[Preanesthetic evaluation of cardiovascular reserve in a patient with dilated cardiomyopathy]

T Oda1, S Otani, N Yoshimura

  • 1Department of Anesthesiology and Critical Care Medicine, Kagoshima University School of Medicine, Japan.

Masui. the Japanese Journal of Anesthesiology
|April 1, 1996
PubMed

Insights

Anesthetic management for abdominal aortic aneurysm with dilated cardiomyopathy requires careful cardiovascular reserve evaluation. Continuous monitoring using transesophageal echocardiography and cardiac output measurement helps maintain hemodynamic stability during surgery.

Area of Science:

  • Cardiovascular Anesthesiology
  • Critical Care Medicine

Background:

  • Anesthetic management for patients with abdominal aortic aneurysm (AAA) and dilated cardiomyopathy (DCM) presents significant challenges due to compromised cardiac function.
  • Preoperative assessment of cardiovascular reserve is crucial for predicting patient tolerance to surgical stress.

Observation:

  • Transesophageal echocardiography (TEE) and continuous cardiac output (CCO) measurements were utilized for intraoperative hemodynamic monitoring.
  • Echocardiographic and hemodynamic data after a 50-meter walk test helped predict allowable ranges for preload, myocardial performance, and heart rate.
  • Left ventricular diastolic dimension (Dd) changes promptly reflected alterations in preload compared to pulmonary capillary wedge pressure.

Findings:

  • Continuous monitoring of Dd, arterial blood pressure, heart rate, and cardiac output successfully maintained hemodynamic variables within predicted allowable ranges.
  • CCO proved effective in detecting abrupt changes in myocardial performance during the procedure.
  • TEE monitoring of preload (Dd) and CCO monitoring of myocardial performance allowed for early detection of hemodynamic shifts.

Implications:

  • Preanesthetic stress testing can evaluate cardiovascular reserve and predict safe hemodynamic variable ranges for high-risk surgical patients.
  • Integrating TEE and CCO monitoring provides a robust strategy for managing complex anesthetic cases involving cardiovascular compromise.
  • This approach enhances patient safety by enabling proactive management of hemodynamic instability during major vascular surgery.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...